Amedisys Statistics
Total Valuation
Amedisys has a market cap or net worth of $2.97 billion. The enterprise value is $3.32 billion.
| Market Cap | 2.97B |
| Enterprise Value | 3.32B |
Important Dates
The last earnings date was Wednesday, April 24, 2024, after market close.
| Earnings Date | Apr 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Amedisys has 32.67 million shares outstanding. The number of shares has decreased by -0.17% in one year.
| Shares Outstanding | 32.67M |
| Shares Change (YoY) | -0.17% |
| Shares Change (QoQ) | -0.60% |
| Owned by Insiders (%) | 2.26% |
| Owned by Institutions (%) | 95.13% |
| Float | 31.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 19.59 |
| PS Ratio | 1.33 |
| Forward PS | 1.26 |
| PB Ratio | 2.79 |
| P/FCF Ratio | 22.58 |
| PEG Ratio | 1.35 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.57, with an EV/FCF ratio of 25.23.
| EV / Earnings | n/a |
| EV / Sales | 1.49 |
| EV / EBITDA | 25.57 |
| EV / EBIT | 46.09 |
| EV / FCF | 25.23 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.05 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 3.75 |
| Debt / FCF | 3.70 |
| Interest Coverage | 2.30 |
Financial Efficiency
Return on equity (ROE) is -0.90% and return on invested capital (ROIC) is -2.40%.
| Return on Equity (ROE) | -0.90% |
| Return on Assets (ROA) | -0.50% |
| Return on Capital (ROIC) | -2.40% |
| Revenue Per Employee | $117,704 |
| Profits Per Employee | -$513 |
| Employee Count | 19,000 |
| Asset Turnover | 1.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Amedisys has paid $50.56 million in taxes.
| Income Tax | 50.56M |
| Effective Tax Rate | 123.88% |
Stock Price Statistics
The stock price has increased by +15.60% in the last 52 weeks. The beta is 0.86, so Amedisys's price volatility has been lower than the market average.
| Beta (1Y) | 0.86 |
| 52-Week Price Change | +15.60% |
| 50-Day Moving Average | 92.65 |
| 200-Day Moving Average | 93.10 |
| Relative Strength Index (RSI) | 37.77 |
| Average Volume (30 Days) | 283,372 |
Short Selling Information
The latest short interest is 2.49 million, so 7.62% of the outstanding shares have been sold short.
| Short Interest | 2.49M |
| Short Previous Month | 3.12M |
| Short % of Shares Out | 7.62% |
| Short % of Float | 7.80% |
| Short Ratio (days to cover) | 7.11 |
Income Statement
In the last 12 months, Amedisys had revenue of $2.24 billion and -$9.75 million in losses. Loss per share was -$0.30.
| Revenue | 2.24B |
| Gross Profit | 990.87M |
| Operating Income | 156.39M |
| Pretax Income | 40.81M |
| Net Income | -9.75M |
| EBITDA | 129.93M |
| EBIT | 72.09M |
| Loss Per Share | -$0.30 |
Balance Sheet
The company has $138.86 million in cash and $487.21 million in debt, giving a net cash position of -$348.35 million or -$10.66 per share.
| Cash & Cash Equivalents | 138.86M |
| Total Debt | 487.21M |
| Net Cash | -348.35M |
| Net Cash Per Share | -$10.66 |
| Equity / Book Value | 1.07B |
| Book Value Per Share | 32.65 |
| Working Capital | 23.21M |
Cash Flow
In the last 12 months, operating cash flow was $137.19 million and capital expenditures -$5.48 million, giving a free cash flow of $131.70 million.
| Operating Cash Flow | 137.19M |
| Capital Expenditures | -5.48M |
| Free Cash Flow | 131.70M |
| FCF Per Share | $4.04 |
Margins
Gross margin is 44.31%, with operating and profit margins of 6.99% and -0.44%.
| Gross Margin | 44.31% |
| Operating Margin | 6.99% |
| Pretax Margin | 1.82% |
| Profit Margin | -0.44% |
| EBITDA Margin | 5.81% |
| EBIT Margin | 3.22% |
| FCF Margin | 5.89% |
Dividends & Yields
Amedisys does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.17% |
| Shareholder Yield | 0.17% |
| Earnings Yield | -0.33% |
| FCF Yield | 4.43% |
Analyst Forecast
The average price target for Amedisys is $99.50, which is 9.28% higher than the current price. The consensus rating is "Hold".
| Price Target | $99.50 |
| Price Target Difference | 9.28% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 5, 2006. It was a forward split with a ratio of 4:3.
| Last Split Date | Dec 5, 2006 |
| Split Type | Forward |
| Split Ratio | 4:3 |
Scores
Amedisys has an Altman Z-Score of 3.62 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.62 |
| Piotroski F-Score | 4 |